Drugs / RUTI®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04919239 | Sep 2021 → Jun 2025 | pulmonary tuberculosis | Archivel Farma S.L. | Completed | No outcome recorded |
Press releases naming this drug 10 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUTI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04919239 ↗ |
| Modality | Vaccine | “RUTI® vaccine” NCT04919239 ↗ |
| Route | Intramuscular | “in the right/left deltoid muscle” NCT04919239 ↗ |